CC
LLY icon

Cypress Capital’s Eli Lilly LLY Stock Holding History

Cypress Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-300
Closed -$56.6K – 230
2024
Q2 		$56.6K Buy
+300
New +$240K 0.01% 108

Other funds holding LLY

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Cypress Capital's LLY Position: Q2 2026 in Review

Cypress Capital reduced its Eli Lilly (LLY) stake by 0.8% in Q2 2026, selling an estimated $6.13K and leaving 746 shares worth $895K. The position accounts for 0.24% of the portfolio, ranked #59.

Cypress Capital first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. The position peaked at $981K in Q2 2024. 961 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cypress Capital held 746 shares of Eli Lilly worth $895K as of Q2 2026.
  • Cypress Capital sold 6 Eli Lilly shares in Q2 2026, an estimated $6.13K.
  • Eli Lilly made up 0.24% of Cypress Capital's portfolio in Q2 2026, its #59 holding.
  • Cypress Capital first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • Cypress Capital's Eli Lilly position peaked at $981K in Q2 2024.
  • 961 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cypress Capital's 13F filing for Q2 2026, filed 17 Jul 2026.